Skip to main content
. 2020 May 15;10(5):e034298. doi: 10.1136/bmjopen-2019-034298

Figure 3.

Figure 3

The effect of pharmacy point-of-care-testing on international normalised ratio (INR) percentage of time in therapeutic range.